Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Clot-busting drug tenecteplase shows promising results for stroke recovery

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Oct 2024

Study: Fear of cancer recurrence is common among adult survivors of childhood cancer

A new study by Concordia researchers suggests that one-third of adult survivors of childhood cancer experience a fear of cancer recurrence so severe that it can seriously impact their daily lives.

15 Oct 2024

New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans

A study using 7T QSM identifies microstructural changes in the brainstem of COVID-19 survivors, suggesting links to long-term neuroinflammatory responses.

10 Oct 2024

Research shows link between multiple sclerosis to increased risk of certain cancers

A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS.

9 Oct 2024

Identical twins study uncovers insights into multiple sclerosis mechanisms

Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system.

4 Oct 2024

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

New study could lead to a more potent treatment option for multiple sclerosis

Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath.

2 Oct 2024

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

Researchers at NYU Langone Health were awarded $1.6 million from the National Institutes of Health (NIH) to investigate changes in the eye that may indicate early signs of Alzheimer's disease and Parkinson's disease.

2 Oct 2024

Foundation receives $100,000 to advance MS care

The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) recently received a generous donation of $100,000 from EMD Serono Inc., in honor of June Halper, MSN, APN-C, FAAN, MSCN. Ms. Halper a longtime pioneer in the comprehensive care movement for multiple sclerosis (MS), and leading nurse practitioner and MS advocate, passed away on July 24, 2024, at the age of 86, working until her final days as CEO of the CMSC, FCMSC and IOMSN (International Organization of MS Nurses).

26 Sep 2024

Research highlights negative brain health outcomes among LGBTQ+ individuals

LGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

25 Sep 2024

Research questions effectiveness of MS medications in slowing disability progression

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment.

25 Sep 2024

Study links initial symptoms to long-term disability in multiple sclerosis

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes.

24 Sep 2024

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.

24 Sep 2024

Study reveals biomarkers that predict disability worsening in multiple sclerosis

A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).

19 Sep 2024

Philanthropic investment establishes research center to advance precision diagnosis for diseases

An outstanding $21 million philanthropic investment will establish a pioneering research center to advance precision diagnosis for diseases that affect millions of Australians.

19 Sep 2024

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.

19 Sep 2024

Therapeutic inertia in the treatment of women with multiple sclerosis revealed

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.

18 Sep 2024

MIND diet may reduce cognitive decline risk, study suggests

People whose diet more closely resembles the MIND diet may have a lower risk of cognitive impairment, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology. Results were similar for Black and white participants.

18 Sep 2024

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Sep 2024

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.

18 Sep 2024

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Clot-busting drug tenecteplase shows promising results for stroke recovery

Study: Fear of cancer recurrence is common among adult survivors of childhood cancer

New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans

Research shows link between multiple sclerosis to increased risk of certain cancers

Identical twins study uncovers insights into multiple sclerosis mechanisms

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

New study could lead to a more potent treatment option for multiple sclerosis

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

Foundation receives $100,000 to advance MS care

Research highlights negative brain health outcomes among LGBTQ+ individuals

Research questions effectiveness of MS medications in slowing disability progression

Study links initial symptoms to long-term disability in multiple sclerosis

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Study reveals biomarkers that predict disability worsening in multiple sclerosis

Philanthropic investment establishes research center to advance precision diagnosis for diseases

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

Therapeutic inertia in the treatment of women with multiple sclerosis revealed

MIND diet may reduce cognitive decline risk, study suggests

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in